Endovascular treatment in CFA lesions: a promising technique
Barely out of the joint session PVI@EuroPCR dedicated to Interventional, Yann Gouëffic (Saint Joseph Hospital, Paris) shares the key points of the topo he presented on endovascular treatment as an option to treat common femoral lesions (CFA). He gives a brief overview of the existing evidences, introduces approach as well as likely outcomes.
Professor of Vascular Surgery
President of the association of the french university hospitals for clinical research
Conflicts of interest:
Research funding from Predisurge, Biotronik, WL Gore, GE Healthcare
Honoraria from Abbott, BD, Bentely, Biotronik, Boston Scientific, Cook, Eclevar Medtech, GE Healthcare, Ivascular, Medtronic, Penumbra, Sensome, Shockwave medical, WL Gore (consulting, medical advisory board, educational course, speaking)
